Detalles de la búsqueda
1.
Identification of mild cognitive impairment in ACTIVE: algorithmic classification and stability.
J Int Neuropsychol Soc
; 19(1): 73-87, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23095218
2.
Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
Neuroimage
; 60(4): 2316-22, 2012 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22348880
3.
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
Proc Natl Acad Sci U S A
; 106(16): 6820-5, 2009 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-19346482
4.
Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers.
Neuroimage
; 54(3): 1896-902, 2011 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20888920
5.
Characterizing Alzheimer's disease using a hypometabolic convergence index.
Neuroimage
; 56(1): 52-60, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21276856
6.
Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
Neuroimage
; 49(1): 169-76, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19631758
7.
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative.
Neuroimage
; 51(2): 654-64, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20202480
8.
Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups.
Neuroimage
; 47(4): 1678-90, 2009 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19539034
9.
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
Neuroimage
; 45(4): 1107-16, 2009 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19349228
10.
Training and maintaining memory abilities in healthy older adults: traditional and novel approaches.
J Gerontol B Psychol Sci Soc Sci
; 62 Spec No 1: 53-61, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17565165
11.
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.
JAMA Neurol
; 72(3): 316-24, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25580592
12.
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
J Clin Psychiatry
; 75(6): 652-60, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24816373
13.
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.
Neurology
; 83(3): 253-60, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24928124
14.
Memory training in the ACTIVE study: how much is needed and who benefits?
J Aging Health
; 25(8 Suppl): 21S-42S, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23103452
15.
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.
JAMA Neurol
; 70(3): 320-5, 2013 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23599929
16.
Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose.
PLoS One
; 8(6): e67163, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23840615
17.
Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.
Neurobiol Aging
; 33(4): 827.e11-9, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21821316
18.
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
Lancet Neurol
; 11(12): 1048-56, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23137948
19.
Florbetapir PET analysis of amyloid-ß deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.
Lancet Neurol
; 11(12): 1057-65, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23137949
20.
Modeling change in memory performance and memory perceptions: findings from the ACTIVE study.
Psychol Aging
; 26(3): 518-24, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21463064